Redefine Success
Dr. Roxie Mooney is a commercialization strategist, operator, and board-level advisor with deep experience guiding healthtech and pharmacy companies through growth, valuation inflection points, and exits.
Her work bridges doctoral-level rigor with hands-on execution in complex, regulated markets. He research and practice focus on how healthcare technology is commercialized, scaled, and valued —and how growth stories stand up under buyer scrutiny.
Dr. Roxie has been directly involved in four successful exits, including helping scale BioPlus Specialty Pharmacy from approximately $750M to $2B in revenue, leading to acquisitions by Nautic Partners and Elevance Health.
Her role at Legacy DNA is to set the standards, frameworks, and rigor that guide the firm’s work, ensuring every engagement reflects the same discipline, judgment, and outcome focus.
